$MDT - Primed for the next leg upNYSE:MDT broke out from the channel and is consolidating in a flag. It looks primed for the next leg up. 🚀
Price targets:
$92
$96
$100
$104
Downside risk:
$76
3.16USD
3.76 BUSD
31.23 BUSD
1.33 B
About MEDTRONIC PLC USD0.0001
Sector
Industry
CEO
Geoffrey Straub Martha
Website
Headquarters
Dublin
Employees (FY)
95 K
Founded
2014
ISIN
IE00BTN1Y115
FIGI
BBG00JRQT8Y5
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Stocks pairs trading: BMY vs MDTIn the medical device and pharmaceutical sectors, contrasting financial metrics and market dynamics between Medtronic plc (MDT) and Bristol-Myers Squibb Company (BMY) present a compelling scenario for investors. Based on their respective financial performances and market positions, it could be strat
MDT Medtronic plc Options Ahead of EarningsIf you haven`t bought the previous dip in MDT:
Then analyzing the options chain and the chart patterns of MDT Medtronic plc prior to the earnings report this week,
I would consider purchasing the 75usd strike price at the money Calls with
an expiration date of 2023-11-24,
for a premium of approxim
i.Wish $MDT keep going down furtherMDT has increased its dividend for 46 consecutive years. Easing supply-chain issues, new product launches, and higher demand for medical procedures have been supporting Medtronic’s performance.
In addition, the company is focusing on digital technology adoption and cost-saving measures, with a targ
$MDT - Can 200DMA provide a support?NYSE:MDT Ouch! A false break out and a fast breakdown. Lets see if 200DMA can provide some support. Otherwise, a trip down to $76 is possible. ER is on 22nd August. Its a make it or break it quarter. 👀
Argus Market Mover on 06/20/2023: MDTcopy & paste directly from Argus,
Medtronic is one of the world's largest medical technology and solutions companies. The company’s devices focus on cardiac rhythm management, spinal and surgical navigation technologies, treatments
for diabetes and neurological conditions, vascular therapies, and
$MDT - Looks goodNYSE:MDT Breaking out of the descending wedge with a ☕️.
If the stock can break above $92, it can run to $105. Breaking below $84 would be bearish. $89 - 92 is going to be a hard resistance to overcome.
Targets - $92, $100, $105
Downside risk - $76
$MDT with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:MDT after a negative over reaction following its earnings release placing the stock in drift D with an expected accuracy of 40%.
Campaign Trading Medtronic to the $130 zoneyep ... Medtronic has been taking advantage of A.I. for years.
"By harnessing the power of AI, data analytics, and sensors, Medtronic's healthcare technologies are helping clinicians create individualized treatment plans to achieve better outcomes for more people in more places. From the world’s fi
MDT is set to recover - overreaction on the outlookMDT beat analysts' estimates but guided somewhat dovish. The market has penalized the stock - it could be an overreaction. The management executes well on the business. I expect higher prices.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0Y6X is 80.23 USD — it has decreased by 0.83% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange MEDTRONIC PLC USD0.0001 stocks are traded under the ticker 0Y6X.
MEDTRONIC PLC USD0.0001 is going to release the next earnings report on May 23, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for MEDTRONIC PLC USD0.0001 has a max estimate of 104.00 USD and a min estimate of 75.00 USD.
0Y6X earnings for the last quarter are 1.25 USD whereas the estimation was 1.18 USD which accounts for 5.78% surprise. Estimated earnings for the next quarter are 1.26 USD. See more details about MEDTRONIC PLC USD0.0001 earnings.
MEDTRONIC PLC USD0.0001 revenue for the last quarter amounts to 7.98 B USD despite the estimated figure of 7.93 B USD. In the next quarter revenue is expected to reach 7.95 B USD.
Yes, you can track MEDTRONIC PLC USD0.0001 financials in yearly and quarterly reports right on TradingView.
Like other stocks, 0Y6X shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDTRONIC PLC USD0.0001 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 95.00 K employees. See our rating of the largest employees — is MEDTRONIC PLC USD0.0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDTRONIC PLC USD0.0001 EBITDA is 8.65 B USD, and current EBITDA margin is 26.28%. See more stats in MEDTRONIC PLC USD0.0001 financial statements.